XLCART001 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects
Clinical trial NCT03598179 · UNKNOWN
Trial details
- NCT number
- NCT03598179
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-01
- Primary completion
- 2019-12-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.